Phage Based Diagnostics

01359 231856

Twitter Youtube Linkedin Envelope
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us
Menu
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us
Search
Generic filters

Actiphage identifies strain of mycobacteria in blood of bison

Results presented at ICP (12-16th June) from first study in North American bison, shows capacity of Actiphage to sub-type mycobacteria in blood.
  • May 26, 2022
  • Actiphage, Latest, MAP, Other animals
bison MAP diagnostic

The role of Actiphage® as a powerful research tool for tuberculosis-related diseases is to be explored at the 15th International Association for Paratuberculosis Colloquium (ICP2022) in Dublin on 12 – 16th June 2022. Results from a study of co-infection of bison will be presented and the new Johne’s Disease Testing Service will be discussed on the Biosellal stand where PBD Biotech has a presence.


First results show Actiphage detects co-infection in bison

The poster, to be presented by Professor Cath Rees of the University of Nottingham, is the first time that Actiphage has been applied to detecting co-infection of North American bison. The nature of infection in the seven bison was unknown, so Actiphage was used as a lysing agent to extract DNA from viable mycobacterial cells, then different PCR assays were applied to identify the type of Mycobacterium causing the infection.

Actiphage
Microscopy image of bacteriophage (orange) and a mycobacterium (green) (c) PBD Biotech

The robust nature of the mycobacteria means that extracting the DNA for identification by PCR is problematic and physical or chemical lysis methods are inefficient. In contrast, the phage lysis has evolved to be highly efficient and allows Actiphage to detect very low (<10) numbers of cells.

Additionally, since the assay directly detects the presence of the organism rather than an immune response, the method can be applied to any species of animal. Actiphage’s developer, PBD Biotech, has recently launched a Johne’s Disease testing service that uses Actiphage to detect Mycobacterium avium subsp. paratuberculosis (MAP) in the blood of cattle and farmed deer.

The bison study successfully identified the presence of MAP in six animals, of which two also had evidence of M. avium co-infection; in the remaining animal only M. avium was detected. This is an important finding as it shows Actiphage is a powerful tool for disease management in species where there is limited availability of immunological tests.

The results demonstrate the ability of Actiphage to successfully extract DNA even when few cells of viable Mycobacteria are present, and offers a utility for both rapid detection and sub-speciation due to it compatibility with existing PCR-based assays.

Early detection of MAP in calves

Actiphage has also been used to detect MAP in the blood of experimentally infected calves (Swift et al., 2020).

Earlier findings from a study by Biosellal and PBD Biotech found that MAP could be detected in the blood of day-old calves born from MAP-positive mothers. Previously Johne’s Disease was only reliably diagnosed in 18 – 24-month calves after they had started to shed MAP into their faeces.

The study involved monthly testing on calves from three different herds – born from MAP-positive and MAP-negative cows – using PBD Biotech’s Actiphage kit and Biosellal’s Bio-T kit® MAP PCR on blood samples. This landmark study showed that there was a window of opportunity between birth and shedding of MAP to detect and control the disease.

See us at ICP on Biosellal stand

Jonnie Yewdall, Commercial Director for PBD Biotech, will be available for discussions at the Biosellal stand at ICP. The Biosellal PCR kit is verified and validated to detect MAP and works with Actiphage.

Diagnostics and detection – Poster Pitches

Tuesday, June 14, 2022, 12:45 PM – 1:00 PM, Main Auditorium, Printworks

Detection of MAP and M. avium co-infection in North American Bison using Actiphage – Prof Cath Rees

Optimization of Actiphage for detection of MAP in different hosts, including humans – Prof Cath Rees

More about ICP 2022

Share:

Related posts

Loading...

Actiphage detects Johne’s disease in vaccinated goat

June 9, 2022
A study presented at ICP 2022 has shown that the blood test Actiphage is able to distinguish between goats that are naturally infected and those vaccinated against Mycobacterium avium subspecies paratuberculosis (MAP), the pathogen that causes Johne’s Disease, supporting the...

Actiphage detects Johne’s disease in vaccinated goat

June 9, 2022
A study presented at ICP 2022 has shown that the blood test Actiphage is able to distinguish between goats that...
Actiphage use as a DIVA test

Actiphage optimised to detect MAP in humans and to support use as ‘DIVA’

June 1, 2022
This is the first time Actiphage has been used to detect MAP in a human blood sample and also to identify a live infection in a vaccinated goat.
Actiphage use as a DIVA test

Actiphage optimised to detect MAP in humans and to support use as ‘DIVA’

June 1, 2022
This is the first time Actiphage has been used to detect MAP in a human blood sample and also to...
Cath Rees

21-23 August 2022

The Science of Artisan Cheese

May 25, 2022
Prof. Cath Rees CSO has spoken at the conference on several occasions and is delighted to be invited back to talk about developments in Actiphage, and its application to test milk for the presence of bTB and MAP.
Cath Rees

21-23 August 2022

The Science of Artisan Cheese

May 25, 2022
Prof. Cath Rees CSO has spoken at the conference on several occasions and is delighted to be invited back to...
cow

Why breakthrough human trials of Actiphage are good news for farmers

May 12, 2022
The findings are a real breakthrough for animal diagnosis as it provides clinical evidence that detection of low levels of mycobacteria in the blood is an indication that the animal is infected and has the potential to develop disease.
cow

Why breakthrough human trials of Actiphage are good news for farmers

May 12, 2022
The findings are a real breakthrough for animal diagnosis as it provides clinical evidence that detection of low levels of...
1 2 … 21 Next »

developers of phage-based diagnostics

Contact Us

PBD Biotech Ltd
Link House, Elm Farm Park,
Great Green, Thurston,
Suffolk IP31 3SH,
United Kingdom

Registered Company Address
Ingenuity Centre,
University of Nottingham,
Innovation Park, Triumph Rd,
Nottingham NG7 2TU,
United Kingdom

T: 01359 231856
info@pbdbio.com

Privacy and cookies policy

© 2022 PBD Biotech Ltd

design: out of house

  • Follow Us!
PBD Biotech

If you are going @CheshireShow there is an opportunity to talk to @ZaraBewizibet senior scientific adviser to Defra TB Policy. She is on the Cheshire Badger Vaccination Project @CBVP2021 stand. Good to see some joined up thinking #BadgerTrust #EndTB

Read More
PBD Biotech

@PeterMullowney Thank you @PeterMullowney for a very productive conference with many inspiring presentations. So good to see everyone @paratb2022

Read More
PBD Biotech

@1GarethWynJones @downtoearthuk_ @clovermad Mum always knows best 😉 Well done @clovermad for hosting.

Read More